News

Zacks Investment Research on MSN10d
JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?
Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...
What's Next: Johnson & Johnson's Earnings Preview
Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...
Devdiscourse2d
Cutting Costs and Innovations: Transformations in Health Sector
The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.
Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...
Seeking Alpha2mon
Johnson & Johnson Just Proved The Bears Wrong Again
Johnson & Johnson has started 2025 better than I expected, ... Also, I want to let you know that my next articles will be about Pfizer, Nvidia, and AbbVie. Reply. Like (1) C. CJlove4all.
ABC Action News4y
J&J vaccine uses different technology than Moderna, Pfizer
The science behind Johnson & Johnson's single-dose COVID-19 vaccine and the Moderna and Pfizer two-shot vaccines is different, but not new.